Sharecafe

Immutep (ASX:IMM) TACTI-002 data presented at ASCO 2022

Immutep Limited ED / CEO Marc Voigt, Chief Scientific and Medical Officer Dr Frédéric Triebel, and Vice President Strategic Development Christian Mueller present on Immutep's latest clinical results.

 

Immutep Limited (ASX:IMM) Executive Director and CEO Marc Voigt, Chief Scientific and Medical Officer Dr Frédéric Triebel, and Vice President Strategic Development Christian Mueller present on Immutep’s latest clinical results.

Serving up fresh finance news, marker movers & expertise.
LinkedIn
Email
X

All Categories